These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23196668)
1. Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Mause SF Thromb Haemost; 2013 Jan; 109(1):5-6. PubMed ID: 23196668 [No Abstract] [Full Text] [Related]
2. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Suades R; Padró T; Vilahur G; Badimon L Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460 [TBL] [Abstract][Full Text] [Related]
3. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis. Suades R; Padró T; Alonso R; Mata P; Badimon L Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539 [TBL] [Abstract][Full Text] [Related]
10. Plasma factor Xa inhibition can predict antithrombotic effects of oral direct factor Xa inhibitors in rabbit atherothrombosis models. Funatsu T; Yamashita A; Kaku S; Iwatsuki Y; Asada Y Thromb Haemost; 2012 Nov; 108(5):896-902. PubMed ID: 23052641 [TBL] [Abstract][Full Text] [Related]
11. Microparticles as new markers of cardiovascular risk in diabetes and beyond. Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919 [TBL] [Abstract][Full Text] [Related]
12. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets. Chen YW; Chen JK; Wang JS Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321 [TBL] [Abstract][Full Text] [Related]
13. Microparticles, malignancy and thrombosis. Zahra S; Anderson JA; Stirling D; Ludlam CA Br J Haematol; 2011 Mar; 152(6):688-700. PubMed ID: 21303355 [TBL] [Abstract][Full Text] [Related]
14. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Eckman PM; John R Circulation; 2012 Jun; 125(24):3038-47. PubMed ID: 22711669 [No Abstract] [Full Text] [Related]
15. Targeting blood thrombogenicity precipitates atherothrombotic events in a mouse model of plaque destabilization. Liu X; Ni M; Ma L; Yang J; Wang L; Liu F; Dong M; Yang X; Zhang M; Lu H; Wang J; Zhang C; Jiang F; Zhang Y Sci Rep; 2015 May; 5():10225. PubMed ID: 25959659 [TBL] [Abstract][Full Text] [Related]
16. [Cell-derived microparticules: key players at the crossroad between inflammation and thrombosis]. Sabatier F; Lacroix R; Leroyer AS; Cointe S; Dignat-George F Transfus Clin Biol; 2011 Apr; 18(2):62-9. PubMed ID: 21444231 [TBL] [Abstract][Full Text] [Related]
17. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation. Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650 [TBL] [Abstract][Full Text] [Related]
18. Does consumption of platelet-derived microparticles in the fibrin clot explain the decrease in their percentage during pregnancy? Patil R; Ghosh K; Mukherjee S; Shetty S Blood Cells Mol Dis; 2016 Mar; 57():115-7. PubMed ID: 26733427 [No Abstract] [Full Text] [Related]
19. Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation. Ouweneel AB; Van Eck M Vascul Pharmacol; 2016 Jul; 82():1-10. PubMed ID: 26545626 [TBL] [Abstract][Full Text] [Related]